149 related articles for article (PubMed ID: 23210914)
1. Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience.
Fujisawa Y; Nakamura Y; Kawachi Y; Otsuka F
J Dermatolog Treat; 2014 Oct; 25(5):419-23. PubMed ID: 23210914
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study.
Fujisawa Y; Yoshino K; Kadono T; Miyagawa T; Nakamura Y; Fujimoto M
Br J Dermatol; 2014 Dec; 171(6):1493-500. PubMed ID: 24814962
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan.
Ito T; Uchi H; Nakahara T; Tsuji G; Oda Y; Hagihara A; Furue M
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1387-94. PubMed ID: 27015673
[TBL] [Abstract][Full Text] [Related]
4. Single institutional experience of the treatment of angiosarcoma of the face and scalp.
Miki Y; Tada T; Kamo R; Hosono MN; Tamiya H; Shimatani Y; Tsutsumi S; Ogino R; Miki Y
Br J Radiol; 2013 Oct; 86(1030):20130439. PubMed ID: 24014066
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients.
Nagano T; Yamada Y; Ikeda T; Kanki H; Kamo T; Nishigori C
Cancer; 2007 Aug; 110(3):648-51. PubMed ID: 17582627
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of taxane regimens in patients with metastatic angiosarcoma.
Hirata T; Yonemori K; Ando M; Hirakawa A; Tsuda H; Hasegawa T; Chuman H; Namikawa K; Yamazaki N; Fujiwara Y
Eur J Dermatol; 2011; 21(4):539-45. PubMed ID: 21697045
[TBL] [Abstract][Full Text] [Related]
7. Pazopanib: an alternative in taxane-resistant cutaneous angiosarcoma.
Fujita M; Endo Y; Fujisawa A; Tanioka M; Kabashima K; Miyachi Y
Eur J Dermatol; 2014; 24(2):267-8. PubMed ID: 24682601
[No Abstract] [Full Text] [Related]
8. Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 cases.
Seo T; Kitamura S; Yanagi T; Ujiie H
J Dermatol; 2022 Mar; 49(3):383-386. PubMed ID: 34881462
[TBL] [Abstract][Full Text] [Related]
9. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
[TBL] [Abstract][Full Text] [Related]
10. Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases.
Fujimura T; Maekawa T; Kato H; Ito T; Matsushita S; Yoshino K; Fujisawa Y; Ishizuki S; Segawa K; Yamamoto J; Hashimoto A; Kambayashi Y; Asano Y
J Dermatol; 2023 Jul; 50(7):912-916. PubMed ID: 36938650
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
Shon W; Jenkins SM; Ross DT; Seitz RS; Beck RA; Ring BZ; Okuno SH; Gibson LE; Folpe AL
J Cutan Pathol; 2011 Dec; 38(12):961-6. PubMed ID: 22050093
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
[TBL] [Abstract][Full Text] [Related]
13. Pazopanib treatment slows progression and stabilizes disease in patients with taxane-resistant cutaneous angiosarcoma.
Ogata D; Yanagisawa H; Suzuki K; Oashi K; Yamazaki N; Tsuchida T
Med Oncol; 2016 Oct; 33(10):116. PubMed ID: 27613162
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous angiosarcoma of the scalp and face in Chinese patients: local experience at a regional hospital in Hong Kong.
Chow TL; Kwan WW; Kwan CK
Hong Kong Med J; 2018 Feb; 24(1):25-31. PubMed ID: 29326400
[TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990.
Mark RJ; Tran LM; Sercarz J; Fu YS; Calcaterra TC; Juillard GF
Arch Otolaryngol Head Neck Surg; 1993 Sep; 119(9):973-8. PubMed ID: 8357598
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection.
Oxenberg J; Khushalani NI; Salerno KE; Attwood K; Kane JM
J Surg Oncol; 2015 Jun; 111(7):829-33. PubMed ID: 25772798
[TBL] [Abstract][Full Text] [Related]
19. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome.
Sasaki R; Soejima T; Kishi K; Imajo Y; Hirota S; Kamikonya N; Murakami M; Kawabe T; Ejima Y; Matsumoto A; Sugimura K
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1032-40. PubMed ID: 11958899
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival.
Li GZ; Fairweather M; Wang J; Orgill DP; Bertagnolli MM; Raut CP
Ann Surg; 2017 Apr; 265(4):814-820. PubMed ID: 28267696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
